These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2107282)

  • 1. Labeling of human clots in vitro with an active-site mutant of t-PA.
    Fry ET; Mack DL; Monge JC; Billadello JJ; Sobel BE
    J Nucl Med; 1990 Feb; 31(2):187-91. PubMed ID: 2107282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label.
    Ord JM; Hasapes J; Daugherty A; Thorpe SR; Bergmann SR; Sobel BE
    Circulation; 1992 Jan; 85(1):288-97. PubMed ID: 1728459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 131I-labeled tissue-type plasminogen activator on de-endothelialized lesions in rabbits.
    Uehara A; Isaka Y; Etani H; Kimura K; Yoneda S; Kamada T; Kozuka T; Nobuhara M
    Nuklearmedizin; 1987 Oct; 26(5):224-8. PubMed ID: 3124079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
    J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid localization of indium-111-labeled inhibited recombinant tissue plasminogen activator in a rabbit thrombosis model.
    Butler SP; Kader KL; Owen J; Wang TS; Fawwaz RA; Alderson PO
    J Nucl Med; 1991 Mar; 32(3):461-7. PubMed ID: 1900886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic visualization of pulmonary thrombi with 123I-YPACK-TNK-tPA.
    De Bruyn VH; Bergmann R; Keyt BA; Bennett WF; Sobel BE
    Coron Artery Dis; 1995 Sep; 6(9):715-21. PubMed ID: 8747877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.
    Emeis JJ; Verheijen JH
    Arzneimittelforschung; 1992 Mar; 42(3):358-62. PubMed ID: 1497699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi.
    Hnatowich DJ; Virzi F; Doherty PW; Wilson J; Rosa J; Ansell JE
    Eur J Nucl Med; 1987; 13(9):467-73. PubMed ID: 3126072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m labeled tissue-type plasminogen activator: preparation, stability and preliminary imaging of thrombus-bearing rats.
    Itoh K; Tsukamoto E; Nishibe T; Sakurama S; Ieko M; Tanabe T; Furudate M
    Ann Nucl Med; 1991 Jul; 5(2):59-64. PubMed ID: 1777351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.
    Shohet RV; Spitzer S; Madison EL; Bassel-Duby R; Gething MJ; Sambrook JF
    Thromb Haemost; 1994 Jan; 71(1):124-8. PubMed ID: 8165630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis.
    Weitz JI; Kuint J; Leslie B; Hirsh J
    Thromb Haemost; 1991 May; 65(5):541-4. PubMed ID: 1651568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of serine or threonine at position 473 of tissue-type plasminogen activator increases its stability in plasma.
    Alibhai M; Chow AM; Paoni NF
    Thromb Haemost; 1996 Jan; 75(1):107-12. PubMed ID: 8713788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro.
    Devcic-Kuhar B; Pfaffenberger S; Gherardini L; Mayer C; Gröschl M; Kaun C; Benes E; Tschachler E; Huber K; Maurer G; Wojta J; Gottsauner-Wolf M
    Thromb Haemost; 2004 Nov; 92(5):980-5. PubMed ID: 15543323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF
    Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.